Health Trials

Epidermal Growth Factor Receptor Egfr Mutated Non Small Cell Lung Cancer Nsclc

1

Review clinical trials related to Epidermal Growth Factor Receptor Egfr Mutated Non Small Cell Lung Cancer Nsclc. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).

Participants needed: 884
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: GenmabUpdated: Jun 3, 2026Locations: 66
Eligibility criteria

Histologically or cytologically confirmed metastatic or unresectable solid malig... [+28]

History of (non-infectious) interstitial lung disease (ILD)/pneumonitis that req... [+1]

Read more